ZORYANA KRAVETS: Open Payments
NPI 1497315659 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 14 payments from 7 companies in 2025. Trend: 2023 $177 · 2024 $123 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $62 |
| ABBVIE INC. | 3 | $52 |
| Dexcom, Inc. | 1 | $50 |
| Lilly USA, LLC | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Dexcom G6 Transmitter, ELIQUIS, Rybelsus, Ozempic, VRAYLAR, UBRELVY, JARDIANCE, NEXLETOL.
Industry payments across SC — which companies pay providers there.
